About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

PSA & What it Means

Many of us, who are dealing with advanced prostate cancer, become understandably concerned about our rising PSA. Given free choice, we all would be much happier if our PSA just disappeared and became undetectable. Granted, a rising PSA is indeed a bad sign, but the rate of rise and how we actually feel is more [...]

The Excitement About Abiraterone – Maybe Our Future

The last few days have seen a lot of commotion and celebrating in the prostate cancer world. There have been multiple news stories of an experimental prostate cancer drug, abiraterone, that has been reported to dramatically shrink prostate cancer tumors and extend survival in 70 to 80 percent of men with aggressive prostate cancer. Abiraterone [...]

Life Threatening Blood Clot- A Hidden Complication Of Prostate Cancer

Studies show more than 90 percent of patients with cancer may experience an increase in the blood's clotting activity, which can lead to a Deep Vein Thrombosis, or DVTs. DVTs can be a life threatening complication which a majority of cancer survivors will face as they wend their way through treatment. DVT occurs when a [...]

One Man’s Experience Using HDK plus HC

Yesterday I wrote about using Keto (HDK) along with HC as a secondary hormone suppressant after traditional hormone blockades have failed to work. The reviews of HDK has been mixed with some doctors shying away from it because of its potential liver toxicity issues. However, for many men fighting advanced prostate cancer HDK is an [...]

Ketoconazole- A Secondary Hormone Manipulation

Ketoconazole (kee-ta-KOE-na-zol), generic name for Nizoral, is an oral drug approved by the FDA for the use to treat fungal infections. However, it has been shown that higher doses of ketoconazole (800-1200mg/day vs 200-400mg/day) also block the production of both free and bound testosterone. Since high-dose Ketoconazole (HDK) has testosterone lowering effects, operating both on [...]

Go to Top